Sarah Pratt is chief operating officer at MedPharm.
Process Development Best Practices for Topical Drug Products
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
QbD Strategies to Secure the Scale-Up of Semi-Solid Topical Formulations